(Q53142237)

11 May 2018

meta-analysis

0 references

title

LDH5 overexpression is associated with poor survival in patients with solid tumors: a meta-analysis. (English)

1 reference

11 May 2018

1 reference

YanHong Yao

1

1 reference

11 May 2018

HaiTao Wang

series ordinal

2

1 reference

11 May 2018

BaoGuo Li

series ordinal

3

1 reference

11 May 2018

publication date

18 April 2014

1 reference

11 May 2018

published in

Tumor Biology

1 reference

11 May 2018

volume

35

1 reference

11 May 2018

issue

7

1 reference

11 May 2018

page(s)

6973-6981

1 reference

11 May 2018

https://scigraph.springernature.com/pub.10.1007/s13277-014-1903-3

exact match

0 references

cites work

Keeping out the bad guys: gateway to cellular target therapy.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1903-3

Hypoxic microenvironment as a cradle for melanoma development and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1903-3

Hypoxia-inducible factors 1alpha and 2alpha are related to vascular endothelial growth factor expression and a poorer prognosis in nodular malignant melanomas of the skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1903-3

On the Origin of Cancer Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1903-3

Rethinking the Warburg effect with Myc micromanaging glutamine metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1903-3

The biology of cancer: metabolic reprogramming fuels cell growth and proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1903-3

Lactate dehydrogenase 5 expression in squamous cell head and neck cancer relates to prognosis following radical or postoperative radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1903-3

Prognostic and predictive role of lactate dehydrogenase 5 expression in colorectal cancer patients treated with PTK787/ZK 222584 (vatalanib) antiangiogenic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1903-3

Interfering with pH regulation in tumours as a therapeutic strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1903-3

LDHA is necessary for the tumorigenicity of esophageal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1903-3

Lactate dehydrogenase-5 (LDH-5) overexpression in non-small-cell lung cancer tissues is linked to tumour hypoxia, angiogenic factor production and poor prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1903-3

Lactate dehydrogenase-5 (LDH-5) expression in human gastric cancer: association with hypoxia-inducible factor (HIF-1alpha) pathway, angiogenic factors production and poor prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1903-3

Lactate dehydrogenase 5 expression in non-Hodgkin B-cell lymphomas is associated with hypoxia regulated proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1903-3

Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1903-3

Quantitative synthesis in systematic reviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1903-3

Quantifying heterogeneity in a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1903-3

Beclin 1 over- and underexpression in colorectal cancer: distinct patterns relate to prognosis and tumour hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1903-3

Lactate-dehydrogenase 5 is overexpressed in non-small cell lung cancer and correlates with the expression of the transketolase-like protein 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1903-3

Prognostic relevance of light chain 3 (LC3A) autophagy patterns in colorectal adenocarcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1903-3

Lactate dehydrogenase 5 expression in Non-Hodgkin lymphoma is associated with the induced hypoxia regulated protein and poor prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1903-3

CD31 angiogenesis and combined expression of HIF-1α and HIF-2α are prognostic in primary clear-cell renal cell carcinoma (CC-RCC), but HIFα transcriptional products are not: implications for antiangiogenic trials and HIFα biomarker studies in primar

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1903-3

Increased LDH5 expression is associated with lymph node metastasis and outcome in oral squamous cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1903-3

Glucose transporter 1 (GLUT1) of anaerobic glycolysis as predictive and prognostic values in neoadjuvant chemoradiotherapy and laparoscopic surgery for locally advanced rectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1903-3

Lactate dehydrogenase 5 expression in melanoma increases with disease progression and is associated with expression of Bcl-XL and Mcl-1, but not Bcl-2 proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1903-3

High lactate dehydrogenase 5 expression correlates with high tumoral and stromal vascular endothelial growth factor expression in gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1903-3

Prognostic factors for progression-free and overall survival with sunitinib targeted therapy and with cytokine as first-line therapy in patients with metastatic renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1903-3

Prognostic factors for survival in patients with advanced oesophageal cancer treated with cisplatin-based combination chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1903-3

Comparison of metabolic pathways between cancer cells and stromal cells in colorectal carcinomas: a metabolic survival role for tumor-associated stroma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1903-3

Lactate dehydrogenase 5 (LDH5) relates to up-regulated hypoxia inducible factor pathway and metastasis in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1903-3

Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1903-3

LDH-A silencing suppresses breast cancer tumorigenicity through induction of oxidative stress mediated mitochondrial pathway apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1903-3

Lactate dehydrogenase A is overexpressed in pancreatic cancer and promotes the growth of pancreatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1903-3

Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1903-3

Small-molecule inhibitors of human LDH5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1903-3

Hypoxic Regulation of Lactate Dehydrogenase A

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1903-3

BNIP3 expression in endometrial cancer relates to active hypoxia inducible factor 1 pathway and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1903-3

Lactate dehydrogenase 5 (LDH-5) expression in endometrial cancer relates to the activated VEGF/VEGFR2(KDR) pathway and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1903-3

Lactate Dehydrogenase 5 Expression in Operable Colorectal Cancer: Strong Association With Survival and Activated Vascular Endothelial Growth Factor Pathway—A Report of the Tumour Angiogenesis Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1903-3

Phosphorylated pVEGFR2/KDR receptor expression in uveal melanomas: relation with HIF2α and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1903-3

On respiratory impairment in cancer cells

21 January 2018

1 reference

12 December 2020

Beclin-1 and LC3A expression in cutaneous malignant melanomas: a biphasic survival pattern for beclin-1

1 reference

12 December 2020

Hypoxia Response Elements in the Aldolase A, Enolase 1, and Lactate Dehydrogenase A Gene Promoters Contain Essential Binding Sites for Hypoxia-inducible Factor 1

1 reference

12 December 2020

Diverging prognostic impacts of hypoxic markers according to NSCLC histology

1 reference

12 December 2020

Comparison of glycolytic enzyme and isoenzyme activity in breast cancers and dysplasia.

1 reference

12 December 2020

Long-term survival is linked to serum LDH and partly to tumour LDH-5 in NSCLC.

1 reference

12 December 2020

10.1007/S13277-014-1903-3

Identifiers

DOI

1 reference

11 May 2018

1 reference

11 May 2018